Summary:
- Liz Parrish, CEO of BioViva, underwent experimental gene therapy in 2015 to potentially slow down her aging process.
- The therapy aimed to activate the telomerase enzyme, which can help maintain the length of telomeres (protective caps on the ends of chromosomes) and potentially extend lifespan.
- While the long-term effects of Parrish's treatment are still being studied, her case highlights the potential of gene therapy for addressing aging and age-related diseases.